The Claim
Glaucoma patients who develop retinal vein occlusion have baseline visual field damage (mean deviation: −5.98 ± 9.05 dB) that is not significantly different from that of glaucoma patients who do not develop retinal vein occlusion (mean deviation: −3.70 ± 4.70 dB; p = 0.114), indicating that retinal vein occlusion is not a direct consequence of advanced glaucomatous neurodegeneration.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People with glaucoma who later develop retinal vein occlusion have the same level of initial vision loss as those who do not develop retinal vein occlusion, suggesting that retinal vein occlusion does not result solely from advanced glaucoma-related nerve damage.
See the scientific wording
Glaucoma patients who develop retinal vein occlusion show no significant difference in baseline visual field damage (mean deviation: −5.98 ± 9.05 dB vs. −3.70 ± 4.70 dB; p = 0.114) compared to those who do not, suggesting that RVO is not simply a consequence of advanced glaucomatous neurodegeneration.
When the nervous system fails to properly regulate blood vessel tone, blood flow to the back of the eye drops, causing the walls of retinal veins to stiffen and slow down blood flow. This leads to clot formation in the veins, blocking blood drainage and damaging vision.
What the research says
1 studyGlaucoma patients who later got a blocked vein in their eye had about the same level of vision loss at the start as those who didn’t get the blockage, meaning the blockage isn’t just caused by worse glaucoma.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.